Effect of Proton-Pump Inhibitor on Survival in Chinese Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Receiving Upfront Combinatorial Docetaxel Treatment.

Cancers (Basel) · 2025 · PMC12427316 · PMID 40940975

Europe PMC DOI

hedged sentence

0.0760

closest p · 1.5× alpha

0.0760

boldest claim

The sentences

did not reach statistical significancep = 0.076so close (0.05 < p ≤ 0.1)

While numerically, more patients in the No-PPI group achieved a PSA nadir of <0.2 ng/mL, this result did not reach statistical significance (25.3% vs. 9.1%, p = 0.076).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.